Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.

Autor: Laurence, VM, Ward, R, Dennis, IF, Bleehen, NM, Laurence, V M, Dennis, I F, Bleehen, N M

Publikováno v: British Journal of Cancer; Jul1995, Vol. 72 Issue 1, p198-205, 8p

Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancer.

Autor: Eccles BK; Royal Bournemouth Hospital, NHS Foundation Trust, Dorset, UK., Geldart TR, Laurence VM, Bradley KL, Lwin MT

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2011 Jul; Vol. 3 (4), pp. 163-70.

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.

Autor: Fenwick JD; Department of Medical Physics, Clatterbridge Centre for Oncology, Clatterbridge Road, Wirral CH63 4JY, UK. john.fenwick@ccotrust.nhs.uk, Nahum AE, Malik ZI, Eswar CV, Hatton MQ, Laurence VM, Lester JF, Landau DB

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2009 May; Vol. 21 (4), pp. 343-60. Date of Electronic Publication: 2009 Feb 20.

Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer.

Autor: Falk SJ; MRC Unit, MRC Centre, Cambridge, UK., Maughan TS, Laurence VM, Lamont A, Boote D, Ford JM, Osborne RJ, Bleehen NM

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 1993; Vol. 5 (2), pp. 85-8.